Seeing men and women whose renal cell cancer has spread to their bones for a study of an investigational drug combination to reduce pain.
All participants in this study will take the usual drug to treat renal cancer, but half of the participants will also take another drug that has not yet been approved for advanced renal cell cancer.
What we're hoping for
We are studying whether adding an investigational drug to the usual treatment will lessen the pain and improve the daily life of people whose renal cell cancer has spread to their bones.
ClinicalTrials.gov Identifier: NCT04071223